Literature DB >> 32376559

[18F-FDG PET/CT manifestations of massive type active pulmonary tuberculosis and its differentiation from lung cancer].

Jiamei Gu1, Yunyan Ren1,2, Xiaohui Chen1, Yanping Jiang1, Wenlan Zhou1, Lijuan Wang1, Yanjiang Han1, Qiaoyu Wang1, Hubing Wu1.   

Abstract

OBJECTIVE: To investigate 18F-FDG PET/CT manifestations of massive type active tuberculosis and lung cancer and the differential diagnosis of the two diseases based on 18F-FDG PET/CT findings.
METHODS: We retrospectively collected the data from 74 patients with active tuberculosis and 64 patients with lung cancer, whose lesions presented as solid masses on CT. The demographic and clinical data of the patients, 18F-FDG PET characteristics including SUVmax, 18F-FDG uptake (higher than mediastinal blood pool or not), radioactive defect within the lesion, and the CT findings including the lesion size, signs of cavity, vacuoles, lobulation, smooth border, and mediastinal/lung window ratio (M/L ratio) of the lesions were analyzed. Univariate and multivariate analyses were used to compare the variables between the two groups, and a logistic regression model was established for differentiation of the two diseases. The diagnostic efficiency was evaluated by area under the receiver-operating characteristic (ROC) curve analysis.
RESULTS: No significant differences were found in the quantitative index (SUVmax >2.5 or not) or in the qualitative index (uptake of lesion higher than mediastinal blood pool or not) in PET between massive type active tuberculosis and lung cancer (P>0.05). Univariate analysis revealed that SUVmax, 18F-FDG uptake of the lesion, age, lesion size, signs of cavity, or M/L ratio were not significantly different (P>0.05), but gender, signs of radioactive defect, vacuoles, smooth border and lobulation were significantly different (P < 0.05) between the two diseases. Multivariate analysis showed that gender, signs of radioactive defect, smooth border and lobulation of the lesion were independent factors for discrimination of the two diseases (P < 0.05). A risk prediction model for active tuberculosis was established based on logistic regression analysis: P=1/(1+e-x), X=-0.530+1.978×gender+3.343×radioactive defect +2.846×smooth border-2.116×lobulation. For diagnosis of active tuberculosis, the sensitivity, specificity, accuracy, positive predictive value and negative predictive value of this model were 78.4%, 92.2%, 84.8%, 92.1%, and 78.7%, respectively.
CONCLUSIONS: The combined analysis of gender, signs of radioactive defect, smooth border and lobulation of the lesions is useful for discriminating massive type active tuberculosis from lung cancer in the majority of the patients, whereas 18F-FDG uptake alone has only limited value for a differential diagnosis.

Entities:  

Keywords:  F-18; emission computer; fluorodeoxyglucose; lung cancer; tomography; tomography, X-ray computed; tuberculosis

Mesh:

Substances:

Year:  2020        PMID: 32376559      PMCID: PMC7040769          DOI: 10.12122/j.issn.1673-4254.2020.01.08

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  21 in total

Review 1.  The molecular imaging approach to image infections and inflammation by nuclear medicine techniques.

Authors:  Alberto Signore; Andor W J M Glaudemans
Journal:  Ann Nucl Med       Date:  2011-08-12       Impact factor: 2.668

Review 2.  Imaging evaluation of the solitary pulmonary nodule.

Authors:  Jeffrey S Klein; Samuel Braff
Journal:  Clin Chest Med       Date:  2008-03       Impact factor: 2.878

Review 3.  Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals.

Authors:  Mike Sathekge; Alex Maes; Yves D'Asseler; Mariza Vorster; Christophe Van de Wiele
Journal:  Nucl Med Commun       Date:  2012-06       Impact factor: 1.690

Review 4.  Advances in imaging of tuberculosis: the role of ¹⁸F-FDG PET and PET/CT.

Authors:  Mariza Vorster; Mike M Sathekge; Jamshed Bomanji
Journal:  Curr Opin Pulm Med       Date:  2014-05       Impact factor: 3.155

5.  Risk stratification of solitary pulmonary nodules by means of PET using (18)F-fluorodeoxyglucose and SUV quantification.

Authors:  Aleksandar Grgic; Yildirim Yüksel; Andreas Gröschel; Hans-Joachim Schäfers; Gerhard W Sybrecht; Carl-Martin Kirsch; Dirk Hellwig
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-06       Impact factor: 9.236

6.  Risk of malignancy in pulmonary nodules: A validation study of four prediction models.

Authors:  Ali Al-Ameri; Puneet Malhotra; Helene Thygesen; Paul K Plant; Sri Vaidyanathan; Shishir Karthik; Andrew Scarsbrook; Matthew E J Callister
Journal:  Lung Cancer       Date:  2015-03-28       Impact factor: 5.705

7.  The new tumor, node, and metastasis staging system.

Authors:  Ramón Rami-Porta; Vanessa Bolejack; Peter Goldstraw
Journal:  Semin Respir Crit Care Med       Date:  2011-04-15       Impact factor: 3.119

8.  Dual time-point FDG PET-CT for differentiating benign from malignant solitary pulmonary nodules in a TB endemic area.

Authors:  Mike Machaba Sathekge; Alex Maes; Hans Pottel; Anton Stoltz; Christophe van de Wiele
Journal:  S Afr Med J       Date:  2010-09-07

Review 9.  FDG PET-CT for solitary pulmonary nodule and lung cancer: Literature review.

Authors:  D Groheux; G Quere; E Blanc; C Lemarignier; L Vercellino; C de Margerie-Mellon; P Merlet; S Querellou
Journal:  Diagn Interv Imaging       Date:  2016-08-24       Impact factor: 4.026

10.  Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.

Authors:  Yaichiro Hashimoto; Tetsuya Tsujikawa; Chisato Kondo; Masako Maki; Mitsuru Momose; Atsushi Nagai; Takamasa Ohnuki; Toshio Nishikawa; Kiyoko Kusakabe
Journal:  J Nucl Med       Date:  2006-03       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.